(Q35032547)

5 August 2017

1 reference

title

Induction of prostate apoptosis by alpha1-adrenoceptor antagonists: mechanistic significance of the quinazoline component (English)

1 reference

5 August 2017

1 reference

Anglin IE

1

1 reference

5 August 2017

Glassman DT

series ordinal

2

1 reference

5 August 2017

Kyprianou N

series ordinal

3

1 reference

5 August 2017

publication date

1 January 2002

1 reference

Prostate Cancer and Prostatic Diseases

5 August 2017

published in

1 reference

5 August 2017

volume

5

1 reference

5 August 2017

issue

2

1 reference

5 August 2017

page(s)

88-95

1 reference

5 August 2017

cites work

Cancer statistics, 2000.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500561

Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500561

Effect of patient age on early detection of prostate cancer with serum prostate-specific antigen and digital rectal examination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500561

A controlled trial of leuprolide with and without flutamide in prostatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500561

Apoptosis in prostate carcinogenesis. A growth regulator and a therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500561

Induction of apoptosis in androgen-independent human prostate cancer cells undergoing thymineless death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500561

Adrenergic and Cholinergic Receptors in the Human Prostate, Prostatic Capsule and Bladder Neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500561

Prostatic alpha 1-adrenoceptors and uroselectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500561

Influence of the alpha1-adrenergic antagonist, doxazosin, on noradrenaline-induced modulation of cytoskeletal proteins in cultured hyperplastic prostatic stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500561

Doxazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in mild or moderate hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500561

Induction of prostate apoptosis by doxazosin in benign prostatic hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500561

Alpha 1-adrenoceptor antagonists terazosin and doxazosin induce prostate apoptosis without affecting cell proliferation in patients with benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500561

Doxazosin: a new cytotoxic agent for prostate cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500561

Mechanism of activation of the TGF-beta receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500561

Incidence of apoptosis and cell proliferation in prostate cancer: relationship with TGF-beta1 and bcl-2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500561

Raf induces TGFbeta production while blocking its apoptotic but not invasive responses: a mechanism leading to increased malignancy in epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500561

Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500561

Role of transforming growth factor-beta signaling in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500561

How cells read TGF-beta signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500561

TGFbeta signaling in growth control, cancer, and heritable disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500561

SARA, a FYVE domain protein that recruits Smad2 to the TGFbeta receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500561

Dual role of the Smad4/DPC4 tumor suppressor in TGFbeta-inducible transcriptional complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500561

Combined effect of terazosin and finasteride on apoptosis, cell proliferation, and transforming growth factor-beta expression in benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500561

Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500561

The NF-kappa B and I kappa B proteins: new discoveries and insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500561

Differential immunoreactivity of her-2/neu oncoprotein in prostatic tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500561

Expression of androgen receptor and growth factors in premalignant lesions of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500561

A mechanism of repression of TGFbeta/ Smad signaling by oncogenic Ras

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500561

Epidermal growth factor signaling via Ras controls the Smad transcriptional co-repressor TGIF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500561

The epidermal growth factor receptor engages receptor interacting protein and nuclear factor-kappa B (NF-kappa B)-inducing kinase to activate NF-kappa B. Identification of a novel receptor-tyrosine kinase signalosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500561

A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500561

Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500561

Function and activation of NF-kappa B in the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500561

How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500561

Smad7 is induced by CD40 and protects WEHI 231 B-lymphocytes from transforming growth factor-beta -induced growth inhibition and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500561

Nuclear factor-kappa B regulates induction of apoptosis and inhibitor of apoptosis protein-1 expression in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500561

Unliganded epidermal growth factor receptor dimerization induced by direct interaction of quinazolines with the ATP binding site.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500561

Reduction of human prostate tumor vascularity by the alpha1-adrenoceptor antagonist terazosin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500561

6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinases with enhanced antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500561

Neoadjuvant hormonal therapy improves the therapeutic ratio in patients with bulky prostatic cancer treated with three-dimensional conformal radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500561

7 January 2021

Activation of programmed cell death in the rat ventral prostate after castration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500561

7 January 2021

Combined antitumor effect of suramin plus irradiation in human prostate cancer cells: the role of apoptosis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500561

7 January 2021

The alpha-adrenoceptor subtype mediating the tension of human prostatic smooth muscle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500561

7 January 2021

Alpha1-adrenoceptor subtypes in the human prostate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500561

7 January 2021

Alpha-blockade therapy for benign prostatic hyperplasia: from a nonselective to a more selective alpha1A-adrenergic antagonist

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500561

7 January 2021

Pharmacokinetics of terazosin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500561

7 January 2021

Transforming growth factor beta 1 transduced mouse prostate reconstitutions: II. Induction of apoptosis by doxazosin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500561

7 January 2021

Expression of transforming growth factor-beta in the rat ventral prostate during castration-induced programmed cell death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500561

7 January 2021

Effect of transforming growth factor-beta 1 on proliferation and death of rat prostatic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500561

7 January 2021

Identification of a cellular receptor for transforming growth factor-beta in rat ventral prostate and its negative regulation by androgens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500561

7 January 2021

Down-regulation of protein and mRNA expression for transforming growth factor-beta (TGF-beta1) type I and type II receptors in human prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500561

7 January 2021

TGF-beta released by apoptotic T cells contributes to an immunosuppressive milieu

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500561

7 January 2021

Epidermal Growth Factor Impairs the Cytochrome C/Caspase-3 Apoptotic Pathway Induced by Transforming Growth Factorβ in Rat Fetal Hepatocytes Via a Phosphoinositide 3-Kinase–Dependent Pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500561

7 January 2021

Suppression of transforming growth factor-beta-induced apoptosis through a phosphatidylinositol 3-kinase/Akt-dependent pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500561

7 January 2021

ErbB kinases and NDF signaling in human prostate cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500561

7 January 2021

Tyrosine kinase inhibitors. 5. Synthesis and structure-activity relationships for 4-[(phenylmethyl)amino]- and 4-(phenylamino)quinazolines as potent adenosine 5'-triphosphate binding site inhibitors of the tyrosine kinase domain of the epidermal gro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500561

7 January 2021

Identifiers

DOI

10.1038/SJ.PCAN.4500561

1 reference

5 August 2017

1 reference